|
⚲
|
| Keyboard |
| QVT Financial LP
✚
|
|
|---|---|
| CRD # | 156508 |
| SEC # | 801-73049 |
| CIK # | 0001290162 |
| AUM | 1,786.7 M (2026-03-31) |
| Employees | 31 (26% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 212-705-8888 |
| Address | 888 Seventh Avenue New York, NY 10106 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($B) |
|---|
| CIK | Period |
|---|---|
| 0001290162 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Roivant Sciences Ltd | 0.7 | ||
| Okeanis ECO Tankers Corp | 0.1 | ||
| Carvana Co | 0.1 | ||
| Goldman Sachs Group Inc | 0.0 | ||
| Allot Communications Ltd | 0.0 | ||
| Nelnet Inc | 0.0 | ||
| Nexstar Broadcasting Group Inc | 0.0 | ||
| New York Times Co | 0.0 | ||
| Nvidia Corp | 0.0 | ||
| Apple Inc | 0.0 | ||
| Pacific Datavision Inc | 0.0 | ||
| Blackstone Secured Lending Fund | 0.0 | ||
| Microsoft Corp | 0.0 | ||
| Zeta Acquisition Corp II | 0.0 | ||
| Liberty Latin America Ltd | 0.0 | ||
| Churchill Capital Corp X/Cayman | 0.0 | ||
| Carmax Inc | 0.0 | ||
| DMY Technology Group Inc III | 0.0 | ||
| Noble Corp PLC | 0.0 | ||
| Birkenstock Holding PLC | 0.0 | ||
| JATT Acquisition Corp | 0.0 | ||
| Trinity Capital Inc | 0.0 | ||
| Summit Therapeutics PLC | 0.0 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| Other | Fourth Avenue FF Opportunities LP - Series 11 | 2026-03-31 | 21.8 M | |
| Other | Fourth Avenue FF Opportunities LP - Series 12 | 2026-03-31 | 2.5 M | |
| Other | Fourth Avenue FF Opportunities LP - Series 13 | 2026-03-31 | 3.5 M | |
| Other | Fourth Avenue FF Opportunities LP - Series 14 | 2026-03-31 | 1.0 M | |
| Other | Fourth Avenue FF Opportunities LP - Series 15 | 2026-03-31 | 6.1 M | |
| Other | Fourth Avenue FF Opportunities LP - Series 16 | 2026-03-31 | 3.0 M | |
| Other | Fourth Avenue FF Opportunities LP - Series 17 | 2026-03-31 | 0.1 M | |
| Other | Fourth Avenue FF Opportunities LP - Series 18 | 2026-03-31 | 5.7 M | |
| Other | QVT Gilead Holdings LLC | 2026-03-31 | 13.0 M | |
| Other | Fourth Avenue FF Opportunities LP - Series 10 | 2025-03-31 | 0.4 M | |
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 7 | 1.8 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 7 | 1.8 |
| By Discretionary | ||
| Discretionary | 7 | 1.8 |
| Non-Discretionary | 0 | 0.0 |
| Total | 7 | 1.8 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.8 | |
| United States Persons | 1.0 | |
| Total | 7 | 1.8 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Ian Pilgrim | Director | 148 | 19 | |
| William Woods | Director | 23 | 6 | |
| W Woods | Director | 68 | 5 | |
| Daniel Gold | Executive Officer | 27 | 2 | |
| Arthur Chu | Executive Officer | 20 | 2 | |
| Nicholas Brumm | Executive Officer | 19 | 2 | |
| Tracy Fu | Executive Officer | 17 | 2 | |
| Qvt Associates GP LLC | Executive Officer | 8 | 2 | |
| Qvt Associates GP | Executive Officer | 5 | 2 | |
| Qvt Financial LP | Executive Officer | 4 | 2 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001290162] | |
| 3 | [0001290162] | |
| 4 | [0001290162] | |
| SC 13D | [0001290162] | |
| SC 13G | [0001290162] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $8.9B |
| Serves | Institutional |
| Fund Types | Hedge Fund, Private Equity |
| LEI | 549300JMMSS9C5S2HO30 |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Roivant Sciences Ltd | |
| QVT Financial LP | |
| Okeanis Eco Tankers Corp | |
| MP Materials Corp / DE | |
| QVT Financial GP LLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Roivant Sciences Ltd ROIV
Common Shares
|
2026-02-13 | Sell | 150,784 | $26.49 | 3,994,268 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2026-02-13 | Sell | 225,000 | $26.50 | 5,962,500 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2026-02-12 | Sell | 150,000 | $26.72 | 4,008,000 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2026-02-12 | Sell | 275,000 | $26.76 | 7,359,000 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2026-02-11 | Sell | 425,000 | $26.67 | 11,334,750 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-12-17 | Sell | 432,718 | $23.05 | 9,974,150 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-12-17 | Sell | 155,076 | $23.02 | 3,569,850 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-12-17 | Sell | 189,538 | $23.17 | 4,391,595 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-12-16 | Sell | 275,000 | $22.93 | 6,305,750 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-12-16 | Sell | 642,282 | $23.08 | 14,823,869 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-11-19 | Sell | 175,000 | $20.24 | 3,542,000 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-11-19 | Sell | 150,000 | $20.20 | 3,030,000 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-11-19 | Sell | 125,000 | $20.16 | 2,520,000 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-11-19 | Sell | 850,000 | $20.25 | 17,212,500 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-06-25 | Other | 6,837,266 | $0.00 | |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-06-25 | Other | 6,205,368 | $0.00 | |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-06-25 | Other | 3,176,245 | $0.00 | |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-06-25 | Other | 19,311,790 | $0.00 | |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-06-25 | Other | 55,443 | $0.00 | |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-06-25 | Other | 1,170,646 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| Comparable Firms | State | AUM |
|---|---|---|
|
D2 Asset Management LP
✚
|
TX | 1,825.9 M |
|
ParaFi Capital LP
✚
|
NY | 1,817.8 M |
|
Tensile Capital Management LP
✚
|
CA | 1,796.0 M |
|
Morgan Creek Capital Management LLC
✚
|
NC | 1,790.2 M |
|
Alta Park Capital LP
✚
|
CA | 1,779.6 M |
|
Great Point Partners LLC
✚
|
CT | 1,777.1 M |
|
OFS Capital Management LLC
✚
|
IL | 1,760.0 M |
|
RCF Management LLC
✚
|
CO | 1,757.0 M |
|
Parkman Healthcare Partners LLC
✚
|
CT | 1,744.0 M |
|
Long Path Partners LP
✚
|
CT | 1,732.8 M |